LONG TERM TREATMENT OF IgA NEPHROPATHY WITH CYCLOSPORINE A

Renal Failure ◽  
2000 ◽  
Vol 22 (1) ◽  
pp. 55-62 ◽  
Author(s):  
Vera Chábová ◽  
Vladimir Tesar ◽  
Jiri Zabka ◽  
Ivan Rychlik ◽  
Miroslav Merta ◽  
...  
Keyword(s):  
Iga Nephropathy ◽  
Cyclosporine A ◽  
Term Treatment ◽  
Long Term Treatment

Long-term treatment of IgA nephropathy with cyclosporin A-a preliminary report

1997 ◽  
Vol 12 (10) ◽  
pp. 2206-2207 ◽  
Author(s):  
V. Chabova ◽  
V. Tesar ◽  
J. Zabka ◽  
I. Rychlik ◽  
M. Merta ◽  
...  
Keyword(s):  
Cyclosporin A ◽  
Iga Nephropathy ◽  
Preliminary Report ◽  
Term Treatment ◽  
Long Term Treatment

scholarly journals Cyclosporine A in Ullrich Congenital Muscular Dystrophy: Long-Term Results

2011 ◽  
Vol 2011 ◽  
pp. 1-10 ◽  
Author(s):  
Luciano Merlini ◽  
Patrizia Sabatelli ◽  
Annarita Armaroli ◽  
Saverio Gnudi ◽  
Alessia Angelin ◽  
...  
Keyword(s):  
Muscular Dystrophy ◽  
Cyclosporine A ◽  
Congenital Muscular Dystrophy ◽  
Respiratory Muscles ◽  
Primary Outcome Measure ◽  
Term Treatment ◽  
Long Term Results ◽  
Long Term Treatment ◽  
Ullrich Congenital Muscular Dystrophy

Six individuals with Ullrich congenital muscular dystrophy (UCMD) and mutations in the genes-encoding collagen VI, aging 5–9, received 3–5 mg/kg of cyclosporine A (CsA) daily for 1 to 3.2 years. The primary outcome measure was the muscle strength evaluated with a myometer and expressed as megalimbs. The megalimbs score showed significant improvement (P=0.01) in 5 of the 6 patients. Motor function did not change. Respiratory function deteriorated in all. CsA treatment corrected mitochondrial dysfunction, increased muscle regeneration, and decreased the number of apoptotic nuclei. Results from this study demonstrate that long-term treatment with CsA ameliorates performance in the limbs, but not in the respiratory muscles of UCMD patients, and that it is well tolerated. These results suggest considering a trial of CsA or nonimmunosuppressive cyclosporins, that retains the PTP-desensitizing properties of CsA, as early as possible in UCMD patients when diaphragm is less compromised.

Long-term treatment with heparin dramatically reduced massive proteinuria in patients with advanced IgA nephropathy

Nephrology ◽  
2002 ◽  
Vol 7 ◽  
pp. A114-A114
Author(s):  
Y ITO ◽  
T KAWAMURA ◽  
M OGURA ◽  
Y UTSUNOMIYA ◽  
T HOSOYA
Keyword(s):  
Iga Nephropathy ◽  
Term Treatment ◽  
Long Term Treatment

scholarly journals Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years

2008 ◽  
Vol 23 (4) ◽  
pp. 581-586 ◽  
Author(s):  
Birgitta Kranz ◽  
Udo Vester ◽  
Rainer Büscher ◽  
Anne-Margret Wingen ◽  
Peter F. Hoyer
Keyword(s):  
Nephrotic Syndrome ◽  
Cyclosporine A ◽  
Minimal Change Nephrotic Syndrome ◽  
Term Treatment ◽  
Minimal Change ◽  
Long Term Treatment

Long-term treatment with heparin dramatically reduced massive proteinuria in patients with advanced IgA nephropathy

Nephrology ◽  
2008 ◽  
Vol 7 ◽  
pp. A114-A114
Author(s):  
Y ITO ◽  
T KAWAMURA ◽  
M OGURA ◽  
Y UTSUNOMIYA ◽  
T HOSOYA
Keyword(s):  
Iga Nephropathy ◽  
Term Treatment ◽  
Long Term Treatment

Hypnotherapy is effective in the long-term treatment of functional dyspepsia

2001 ◽  
Vol 120 (5) ◽  
pp. A115-A115 ◽  
Author(s):  
E CALVERT ◽  
L HOUGHTON ◽  
P COOPER ◽  
P WHORWELL
Keyword(s):  
Functional Dyspepsia ◽  
Term Treatment ◽  
Long Term Treatment

1608: Long-Term Treatment with High Doses of Sildenafil Does Not Up-Regulate the Levels of Phosphodiesterase 5 (Pde5) in the Rat Penis

2004 ◽  
Vol 171 (4S) ◽  
pp. 424-424 ◽  
Author(s):  
Monica G. Ferrini ◽  
Eliane G. Valente ◽  
Jacob Rajfer ◽  
Nestor F. Gonzalez-Cadavid
Keyword(s):  
Term Treatment ◽  
Long Term Treatment ◽  
High Doses ◽  
Phosphodiesterase 5
Sign in / Sign up

Export Citation Format

Share Document